Defending the NIH, the NSF, and the foundation of American science

Advocacy

Feb 6

Written by Marshall Bursis

Marshall Bursis

Open letter to President Trump from biopharma innovators, investors, and patient advocates regarding proposed FDA budget and personnel cuts.

Public Comment: Allow Medicare to cover anti-obesity medications (AOMs) and strengthen patient protection “guardrails” through better oversight of Medicare Advantage Part D (MAPD) plans.

/* Autoscroll fix */